Page last updated: 2024-08-23

bromocriptine and Myelodysplastic Syndromes

bromocriptine has been researched along with Myelodysplastic Syndromes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Liberante, FG; McMullin, MF; Mills, KI; Pouryahya, T; Zhang, SD	1

Other Studies

1 other study(ies) available for bromocriptine and Myelodysplastic Syndromes

Article	Year
Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia. Oncotarget, 2016, Feb-09, Volume: 7, Issue:6 Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Bromocriptine; Case-Control Studies; Cell Proliferation; Dopamine Agonists; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms, Second Primary; Tumor Cells, Cultured	2016

Article

Year

Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia.

Oncotarget, 2016, Feb-09, Volume: 7, Issue:6

Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Bromocriptine; Case-Control Studies; Cell Proliferation; Dopamine Agonists; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms, Second Primary; Tumor Cells, Cultured

2016